The "Fragile" Urethra as a Predictor of Early Artificial Urinary Sphincter Erosion.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
11 2022
Historique:
received: 03 04 2022
revised: 18 06 2022
accepted: 20 06 2022
pubmed: 8 7 2022
medline: 16 11 2022
entrez: 7 7 2022
Statut: ppublish

Résumé

To identify predictors of early artificial sphincter (AUS) erosion among a cohort of men with erosion, who underwent AUS placement by either university or community-based surgeons. The records of all patients with AUS erosions, including men who underwent AUS placement at outside facilities, were retrospectively reviewed. A Cox proportional-hazards model for time to erosion was performed with the predictors being the components of a fragile urethra (history of radiation, prior AUS, prior urethroplasty), androgen deprivation therapy (ADT), trans-corporal (TC), and 3.5 cm cuff, controlling for other risk factors. Kaplan-Meier survival curves and log-rank test compared "fragile" urethras with "not fragile" urethras. All statistical analysis was done using R version 3.5.2. Of the 156 men included, 36% had undergone AUS placement in the community. Median time to erosion was 16.0 months (1.0-240.0 months), and 122 (78%) met at least one fragility criteria. Radiation (HR 2.36, 95% CI 1.52-3.64) and prior urethroplasty (HR 2.12, 95% CI 1.18-3.80) were independently associated with earlier time to erosion. The Kaplan-Meier estimates demonstrate 1- and 5-year survival rates of 76.5% and 50.0%, respectively, for "non-fragile" and 44.1% and 14.8% for "fragile" urethras (P < .0001). In a diverse cohort of men with AUS erosion, men with "fragile" urethras eroded sooner. Radiation and prior urethroplasty were independent risk factors for earlier time to erosion, but prior AUS, ADT, TC and 3.5 cm cuff were not.

Identifiants

pubmed: 35798184
pii: S0090-4295(22)00531-3
doi: 10.1016/j.urology.2022.06.023
pii:
doi:

Substances chimiques

Androgen Antagonists 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

233-236

Subventions

Organisme : NIDDK NIH HHS
ID : R21 DK115945
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK097772
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK082344
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Rachel A Mann (RA)

Department of Urology, University of Minnesota, Minneapolis, MN. Electronic address: Mann0469@umn.edu.

Khushabu Kasabwala (K)

Department of Urology, University of Minnesota, Minneapolis, MN.

Jill C Buckley (JC)

Department of Urology, University of California- San Diego Health, La Jolla, CA.

Thomas G Smith (TG)

Department of Urology, MD Anderson Cancer Center, Houston, TX.

O Lenaine Westney (OL)

Department of Urology, MD Anderson Cancer Center, Houston, TX.

Gregory M Amend (GM)

Department of Urology, University of California- San Francisco, San Francisco, CA.

Benjamin N Breyer (BN)

Department of Urology, University of California- San Francisco, San Francisco, CA.

Bradley A Erickson (BA)

Department of Urology, University of Iowa, Iowa City, IA.

Nejd F Alsikafi (NF)

Uropartners, Gurnee, IL.

A Joshua Broghammer (AJ)

Department of Urology, University of Kansas, Kansas City, KS.

Sean P Elliott (SP)

Department of Urology, University of Minnesota, Minneapolis, MN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH